EXPLORING THE CYTOTOXIC AND APOPTOTIC ACTIVITIES OF PRUNUS SPINOSA ECOTYPE EXTRACT TRIGNO ON 3D AND 2D MODELS OF HUMAN CANCER CELLS

Plant-based therapies have played a key role in cancer treatment. Among them, Prunus spinosa L. (blackthorn), rich in phenolic acids, flavonoids, and anthocyanins, has shown anticancer potential.1 Prunus spinosa Trigno ecotype drupe extract (PsT, a plant indigenous to Molise) complexed with a nutra...

Full description

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: PAGEPress Publications 2025-08-01
Series:European Journal of Histochemistry
Subjects:
Online Access:https://www.ejh.it/ejh/article/view/4319
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227338061971456
collection DOAJ
description Plant-based therapies have played a key role in cancer treatment. Among them, Prunus spinosa L. (blackthorn), rich in phenolic acids, flavonoids, and anthocyanins, has shown anticancer potential.1 Prunus spinosa Trigno ecotype drupe extract (PsT, a plant indigenous to Molise) complexed with a nutraceutical activator complex (NAC), consisting of amino acids, vitamins and mineral salt mixtures, was patented by us in the formulation Trigno M (PsT + NAC)®.2 We have shown that it is cytotoxic to several tumour cell lines but not to normal cells. Trigno M reduced the viability of colorectal cancer (CRC) HCT116 and SW480 cells, by inducing apoptosis. It inhibited colony formation compared to 5-fluorouracil (5-FU) and was effective on 3D models. Trigno M significantly delayed tumour growth in CRC xenografts without toxicity.3,4 Furthermore, Trigno M combined with 5-FU inhibited autophagy and enhanced apoptosis in CRC spheroids, suggesting that it could improve efficacy of chemotherapy and reduce side effects.5 Given these promising results, we extended our study to melanoma. Trigno M reduced the viability of WM115, WM266-4, and A375 melanoma cells in a dose- and time-dependent manner, especially on metastatic WM266-4 cells. It induced irreversible morphological changes, cell cycle arrest, and apoptosis via a caspase-dependent mechanism. In conclusion, the Prunus spinosa Trigno ecotype extract could serve as an adjuvant therapy for CRC and melanoma, improving tumour responsiveness to conventional chemotherapy and modulating side effects by reducing cytotoxic drug doses.
format Article
id doaj-art-052c9294a7654440af37a448d57fbe4e
institution Kabale University
issn 1121-760X
2038-8306
language English
publishDate 2025-08-01
publisher PAGEPress Publications
record_format Article
series European Journal of Histochemistry
spelling doaj-art-052c9294a7654440af37a448d57fbe4e2025-08-23T11:19:25ZengPAGEPress PublicationsEuropean Journal of Histochemistry1121-760X2038-83062025-08-0169s210.4081/ejh.2025.4319EXPLORING THE CYTOTOXIC AND APOPTOTIC ACTIVITIES OF PRUNUS SPINOSA ECOTYPE EXTRACT TRIGNO ON 3D AND 2D MODELS OF HUMAN CANCER CELLS Plant-based therapies have played a key role in cancer treatment. Among them, Prunus spinosa L. (blackthorn), rich in phenolic acids, flavonoids, and anthocyanins, has shown anticancer potential.1 Prunus spinosa Trigno ecotype drupe extract (PsT, a plant indigenous to Molise) complexed with a nutraceutical activator complex (NAC), consisting of amino acids, vitamins and mineral salt mixtures, was patented by us in the formulation Trigno M (PsT + NAC)®.2 We have shown that it is cytotoxic to several tumour cell lines but not to normal cells. Trigno M reduced the viability of colorectal cancer (CRC) HCT116 and SW480 cells, by inducing apoptosis. It inhibited colony formation compared to 5-fluorouracil (5-FU) and was effective on 3D models. Trigno M significantly delayed tumour growth in CRC xenografts without toxicity.3,4 Furthermore, Trigno M combined with 5-FU inhibited autophagy and enhanced apoptosis in CRC spheroids, suggesting that it could improve efficacy of chemotherapy and reduce side effects.5 Given these promising results, we extended our study to melanoma. Trigno M reduced the viability of WM115, WM266-4, and A375 melanoma cells in a dose- and time-dependent manner, especially on metastatic WM266-4 cells. It induced irreversible morphological changes, cell cycle arrest, and apoptosis via a caspase-dependent mechanism. In conclusion, the Prunus spinosa Trigno ecotype extract could serve as an adjuvant therapy for CRC and melanoma, improving tumour responsiveness to conventional chemotherapy and modulating side effects by reducing cytotoxic drug doses. https://www.ejh.it/ejh/article/view/4319NUTRACEUTICALS: NEW PATHWAYS FOR CELLULAR HEALTH BEYOND FOODS
spellingShingle EXPLORING THE CYTOTOXIC AND APOPTOTIC ACTIVITIES OF PRUNUS SPINOSA ECOTYPE EXTRACT TRIGNO ON 3D AND 2D MODELS OF HUMAN CANCER CELLS
European Journal of Histochemistry
NUTRACEUTICALS: NEW PATHWAYS FOR CELLULAR HEALTH BEYOND FOODS
title EXPLORING THE CYTOTOXIC AND APOPTOTIC ACTIVITIES OF PRUNUS SPINOSA ECOTYPE EXTRACT TRIGNO ON 3D AND 2D MODELS OF HUMAN CANCER CELLS
title_full EXPLORING THE CYTOTOXIC AND APOPTOTIC ACTIVITIES OF PRUNUS SPINOSA ECOTYPE EXTRACT TRIGNO ON 3D AND 2D MODELS OF HUMAN CANCER CELLS
title_fullStr EXPLORING THE CYTOTOXIC AND APOPTOTIC ACTIVITIES OF PRUNUS SPINOSA ECOTYPE EXTRACT TRIGNO ON 3D AND 2D MODELS OF HUMAN CANCER CELLS
title_full_unstemmed EXPLORING THE CYTOTOXIC AND APOPTOTIC ACTIVITIES OF PRUNUS SPINOSA ECOTYPE EXTRACT TRIGNO ON 3D AND 2D MODELS OF HUMAN CANCER CELLS
title_short EXPLORING THE CYTOTOXIC AND APOPTOTIC ACTIVITIES OF PRUNUS SPINOSA ECOTYPE EXTRACT TRIGNO ON 3D AND 2D MODELS OF HUMAN CANCER CELLS
title_sort exploring the cytotoxic and apoptotic activities of prunus spinosa ecotype extract trigno on 3d and 2d models of human cancer cells
topic NUTRACEUTICALS: NEW PATHWAYS FOR CELLULAR HEALTH BEYOND FOODS
url https://www.ejh.it/ejh/article/view/4319